VERV
Price:
$11.13
Market Cap:
$994.04M
Verve Therapeutics, Inc. is a biotechnology firm dedicated to pioneering gene-editing treatments for individuals afflicted with cardiovascular diseases. Their flagship experimental therapy, VERVE-101, represents a singular gene-editing intervention engineered to irreversibly inactivate the PCSK9 gene within the liver. The company is also progressing with an ANGPTL3 program, which similarly aims to permanently switch off the ANGPTL3 gene in the liver. To support its endeavors, Verve maintains several key partnerships, including a collaboration and licensing pact with Beam Therapeutics Inc., a development and option agreement with Acuitas Therapeutics, Inc., and a Cas9 gene-editing technology ...[Read more]
Industry
Biotechnology
IPO Date
2021-06-17
Stock Exchange
NASDAQ
Ticker
VERV
According to Verve Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -5.27. This represents a change of 113.88% compared to the average of -2.47 of the last 4 quarters.
The mean historical PE Ratio of Verve Therapeutics, Inc. over the last ten years is -18.56. The current -5.27 PE Ratio has changed 2.74% with respect to the historical average. Over the past ten years (40 quarters), VERV's PE Ratio was at its highest in in the September 2024 quarter at -2.04. The PE Ratio was at its lowest in in the March 2020 quarter at -41.55.
Average
-18.56
Median
-10.86
Minimum
-48.96
Maximum
-2.40
Discovering the peaks and valleys of Verve Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual PE Ratio = -2.40
Minimum Annual Increase = -55.94%
Minimum Annual PE Ratio = -48.96
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -2.40 | -46.22% |
| 2023 | -4.47 | -32.68% |
| 2022 | -6.64 | -55.94% |
| 2021 | -15.08 | -55.39% |
| 2020 | -33.79 | -30.98% |
The current PE Ratio of Verve Therapeutics, Inc. (VERV) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-4.51
5-year avg
-12.48
10-year avg
-18.56
Verve Therapeutics, Inc.’s PE Ratio is greater than Albireo Pharma, Inc. (-5.61), less than Gracell Biotechnologies Inc. (-1.55), less than Crescent Biopharma, Inc. (-1.62), greater than VectivBio Holding AG (-7.96), less than EQRx, Inc. (5.40), greater than Poseida Therapeutics, Inc. (-6.94), less than Ethzilla Corp. (-0.14), greater than Avid Bioservices, Inc. (-5.61), less than Harpoon Therapeutics, Inc. (-1.14),
| Company | PE Ratio | Market cap |
|---|---|---|
| -5.61 | $915.89M | |
| -1.55 | $197.97M | |
| -1.62 | $487.75M | |
| -7.96 | $1.06B | |
| 5.40 | $1.14B | |
| -6.94 | $925.93M | |
| -0.14 | $56.39M | |
| -5.61 | $798.90M | |
| -1.14 | $865.08M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Verve Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Verve Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Verve Therapeutics, Inc.'s PE Ratio?
How is the PE Ratio calculated for Verve Therapeutics, Inc. (VERV)?
What is the highest PE Ratio for Verve Therapeutics, Inc. (VERV)?
What is the 3-year average PE Ratio for Verve Therapeutics, Inc. (VERV)?
What is the 5-year average PE Ratio for Verve Therapeutics, Inc. (VERV)?
How does the current PE Ratio for Verve Therapeutics, Inc. (VERV) compare to its historical average?